Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Covered Calls for Dummies Thread -- Ignore unavailable to you. Want to Upgrade?

To: Mike Buckley who wrote (4883)	4/14/2007 12:22:22 AM
From: Mike Buckley	Respond to of 5205

I need to clarify something that I wrote poorly. Immediately following news of the advisory committee's votes, the stock gapped up from less than $4 to $18. The following day it got as high as $24 or $25. That's a 6-bagger. I'm reasonably confident that a favorable ruling from the FDA will not propel the stock nearly that high from the current level of $17. My clarification is that I believe a favorably ruling won't propel the stock to anything near a 6-bagger. Instead, I expect the stock to rise to as little as $25 or as much as $40. --Mike Buckley

To: Mike Buckley who wrote (4883)	4/14/2007 8:26:05 AM
From: Bridge Player	Read Replies (1) \| Respond to of 5205

Based on your detailed and thoughtful analysis, as well as your reputation, I will very likely buy back the short call and let the put run until expiration. Thanks.

To: Mike Buckley who wrote (4883)	4/14/2007 12:49:55 PM
From: Bridge Player	Respond to of 5205

I see I've been asleep. Just now awoke to the recent spate of postings on the Gorilla and King board about DNDN. Had been so quite there for quite awhile that I had removed the bookmark.